CMCR Mission Statement

The mission of the Center for Medicinal Cannabis Research (CMCR) is to facilitate high quality scientific studies intended to ascertain the safety and efficacy of cannabis and cannabinoid products and examine alternative forms of administration. The Center aims to be a model resource for health policy planning by virtue of its close collaboration with federal, state, and academic entities, as well as to act as a conduit for educating medical professionals and the public regarding the responsible use of cannabis/cannabinoids as medicine.

Objectives

  1. To conduct and support focused controlled clinical trials on the efficacy of cannabis and cannabinoids in patients diagnosed with a variety of conditions including: chronic pain, seizures or muscle spasms associated with a chronic debilitating condition, psychiatric conditions, HIV/AIDS, or any other serious condition providing sufficient theoretical justification.
  2. To use prospective clinical and observational trials to determine the optimal dosage, timing, and modes of administration of cannabis and cannabinoids in various medical disorders, as well as address issues of safety and toxicity, including the impact of administration on daily functioning and life quality.
  3. To conduct limited pre-clinical studies with direct relevance to understanding cannabis and cannabinoids as therapeutic agents.
  4. To facilitate the implementation of research by assisting investigators in securing relevant regulatory review and approval by state and federal agencies.
  5. To establish a process of rigorous peer review of scientific proposals.
  6. To secure external sources of funding to maximize the scope and size of cannabis and cannabinoid studies.

Thomas Marcotte, PhD

Presentation before the Canadian House of Commons
(September 2017)


Igor Grant, MD

UC San Diego Department of Psychiatry Grand Rounds: Medicinal Cannabis
(July 2017)




Igor Grant, MD

American Psychological Association Plenary Address: Marijuana as Medicine: Can we see past the smoke?
Denver, CO (August 2016)




Barth Wilsey, MD

Marijuana and Cannabinoids: A Neuroscience Research Summit;
Bethesda, MD (March 2016)



THE PSYCHIATRIC AND NEUROCOGNITIVE EFFECTS OF CANNABIS
(PDF)

Igor Grant, MD, FRCP(C) American Association for the Advancement of Science Annual Meeting

McGill University Health Centre - Research Institute
(February 2015)



Copyright © 2018 CENTER FOR MEDICINAL CANNABIS RESEARCH. | University of California, San Diego
cmcr@ucsd.edu | HNRP |